APA (7th ed.) Citation

EC, K., HA, A., Y, Y., & MJ, B. (2020). Disease activity measures at baseline predict structural damage progression: Data from the randomized, controlled AMPLE and AVERT trials. Rheumatology (Oxford, England), 59(8), 2090. https://doi.org/10.1093/rheumatology/kez455

Chicago Style (17th ed.) Citation

EC, Keystone, Ahmad HA, Yazici Y, and Bergman MJ. "Disease Activity Measures at Baseline Predict Structural Damage Progression: Data from the Randomized, Controlled AMPLE and AVERT Trials." Rheumatology (Oxford, England) 59, no. 8 (2020): 2090. https://doi.org/10.1093/rheumatology/kez455.

MLA (9th ed.) Citation

EC, Keystone, et al. "Disease Activity Measures at Baseline Predict Structural Damage Progression: Data from the Randomized, Controlled AMPLE and AVERT Trials." Rheumatology (Oxford, England), vol. 59, no. 8, 2020, p. 2090, https://doi.org/10.1093/rheumatology/kez455.